PURPOSE: To evaluate whether dynamic magnetic resonance (MR) imaging can increase the diagnostic accuracy in suspected local recurrence of rectal carcinoma. MATERIALS AND METHODS: Eighteen patients (seven men, 11 women, aged 26-78 years) with 19 suspect lesions were examined. T1-weighted (pre- and postcontrast) and T2-weighted spin-echo images were read by three observers. Computed tissue-specific enhancement parameters were obtained and displayed on gray-scale images (pharmacokinetic mapping). RESULTS: Reading of the spin-echo images yielded a sensitivity of 91%-100% (confidence interval, 67%, 100%), a specificity of 29%-43% (12%, 67%), and an accuracy of 71%-75% (48%, 91%). Analysis of the MR data showed greater (P = .0038) and faster (P = .0018) enhancement of malignant lesions (n = 12) compared with benign lesions (n = 7). CONCLUSION: Pharmacokinetic mapping of dynamic MR imaging data allows in vivo insight into tissue physiopathology, helping differentiate benign from malignant pelvic lesions in rectal cancer.
PURPOSE: To evaluate whether dynamic magnetic resonance (MR) imaging can increase the diagnostic accuracy in suspected local recurrence of rectal carcinoma. MATERIALS AND METHODS: Eighteen patients (seven men, 11 women, aged 26-78 years) with 19 suspect lesions were examined. T1-weighted (pre- and postcontrast) and T2-weighted spin-echo images were read by three observers. Computed tissue-specific enhancement parameters were obtained and displayed on gray-scale images (pharmacokinetic mapping). RESULTS: Reading of the spin-echo images yielded a sensitivity of 91%-100% (confidence interval, 67%, 100%), a specificity of 29%-43% (12%, 67%), and an accuracy of 71%-75% (48%, 91%). Analysis of the MR data showed greater (P = .0038) and faster (P = .0018) enhancement of malignant lesions (n = 12) compared with benign lesions (n = 7). CONCLUSION: Pharmacokinetic mapping of dynamic MR imaging data allows in vivo insight into tissue physiopathology, helping differentiate benign from malignant pelvic lesions in rectal cancer.
Authors: P H Lai; C F Yang; H B Pan; M T Wu; S T Chu; L P Ger; W C Huang; C C Hsu; C N Lee Journal: AJNR Am J Neuroradiol Date: 1999-09 Impact factor: 3.825
Authors: Verena Plodeck; Nuh N Rahbari; Juergen Weitz; Christoph G Radosa; Michael Laniado; Ralf-Thorsten Hoffmann; Klaus Zöphel; Bettina Beuthien-Baumann; Joerg Kotzerke; Joerg van den Hoff; Ivan Platzek Journal: Eur Radiol Date: 2018-07-06 Impact factor: 5.315
Authors: Zhuoli Zhang; Linfeng Zheng; Weiguo Li; Andrew C Gordon; Yi Huan; Junjie Shangguan; Daniel Procissi; David J Bentrem; Andrew C Larson Journal: Am J Transl Res Date: 2015-09-15 Impact factor: 4.060
Authors: A Toma; E Otsuji; Y Kuriu; K Okamoto; D Ichikawa; A Hagiwara; H Ito; T Nishimura; H Yamagishi Journal: Br J Cancer Date: 2005-07-11 Impact factor: 7.640